R&D Pipeline

Takeda discloses ethical drugs under development that have entered phase 1 clinical trials or above in Japan, the U.S. or Europe. The pipeline is updated each quarter.

R&D Pipeline (As of May 9, 2013)

PDF 1.3MB 19P

About the R&D Pipeline

Clinical trials are conducted on humans for drugs for which basic research and non-clinical trials have been completed. Drugs that have undergone efficacy and safety evaluation via three phases of clinical trials are launched onto the market after approval by the regulatory authorities.

Ensuring Steady Pipeline Approval